CD8A and neoplasm: For example, tumor-associated macrophages (TAM) and regulatory T cells (Tregs) are associated with tumor-promoting function (Nishikawa and Sakaguchi, 2014), while CD8+ T cells are associated with improved clinical outcomes and immunotherapeutic responses (Tumeh et al., 2014).